| No headlines available for GLSAX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
8.98M |
| Category: |
Specialty-Health |
| Total Expense Ratio: |
1.57% |
|
| PERFORMANCE & RISK | 31-Dec-07
| YTD Return: |
12.68% |
| 5y Avg Return: |
12.95% |
| Rank in Category (ytd): |
126 |
| % Rank in Category (ytd): |
62.69% |
| Beta (3y): |
0.70 |
| Morningstar Risk Rating: |
Average |
|
| The investment seeks long-term capital appreciation. The fund invests, under normal conditions, at least 80% of net assets in equity securities issued by U.S. and foreign companies engaged in the development, production, or distribution of products and services that have a health-science orientation. It will invest 25% or more of assets in at least one of the following industry groups: healthcare; pharmaceuticals; biotechnology; medical supplies; medical services and medical devices. The fund is nondiversified. |
|
| Fund Profile |
|
Help
0.07 (0.74%) 
Summary
Add GLSAX to Portfolio 
Download Data
